Item Type | Name |
Academic Article
|
Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.
|
Academic Article
|
Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs.
|
Academic Article
|
Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC.
|
Academic Article
|
Assembly of the kappa preB receptor requires a V kappa-like protein encoded by a germline transcript.
|
Academic Article
|
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.
|
Concept
|
HLA-DR2 Antigen
|
Concept
|
CD24 Antigen
|
Concept
|
Antigen Presentation
|
Concept
|
CD11b Antigen
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
T-Cell Antigen Receptor Specificity
|
Concept
|
Lymphocyte Function-Associated Antigen-1
|
Concept
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
|
Concept
|
HLA-DR4 Antigen
|
Concept
|
Antigen-Presenting Cells
|
Concept
|
B7-1 Antigen
|
Concept
|
Receptors, Antigen, B-Cell
|
Concept
|
B7-2 Antigen
|
Concept
|
HLA-A2 Antigen
|
Academic Article
|
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.
|
Academic Article
|
Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles.
|
Academic Article
|
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.
|
Academic Article
|
Vaccination for leukemia.
|
Academic Article
|
PR1-specific T cells are associated with unmaintained cytogenetic remission of chronic myelogenous leukemia after interferon withdrawal.
|
Academic Article
|
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice.
|
Academic Article
|
Alloreactive CD4+ T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen.
|
Academic Article
|
Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells.
|
Academic Article
|
Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units.
|
Academic Article
|
A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia.
|
Academic Article
|
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.
|
Academic Article
|
HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders.
|
Academic Article
|
2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.
|
Academic Article
|
An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.
|
Academic Article
|
Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.
|
Academic Article
|
LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells.
|
Academic Article
|
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.
|
Academic Article
|
Detection and characterization of a novel subset of CD8?CD57? T cells in metastatic melanoma with an incompletely differentiated phenotype.
|
Academic Article
|
The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.
|
Academic Article
|
A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.
|
Academic Article
|
Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease.
|
Academic Article
|
T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57.
|
Academic Article
|
A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.
|
Academic Article
|
LFA-1 regulates CD8+ T cell activation via T cell receptor-mediated and LFA-1-mediated Erk1/2 signal pathways.
|
Academic Article
|
Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.
|
Academic Article
|
PD-L1 expression in triple-negative breast cancer.
|
Academic Article
|
CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis.
|
Academic Article
|
PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.
|
Academic Article
|
Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells
|
Academic Article
|
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.
|
Academic Article
|
Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo.
|
Academic Article
|
Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.
|
Academic Article
|
A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.
|
Academic Article
|
Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer.
|
Academic Article
|
Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.
|
Academic Article
|
Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.
|
Academic Article
|
Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes.
|
Academic Article
|
A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2.
|
Concept
|
MART-1 Antigen
|
Concept
|
B7-H1 Antigen
|
Academic Article
|
Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia.
|
Academic Article
|
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia.
|
Academic Article
|
Tsyn-seq: a T cell synapse-based antigen identification platform.
|